AZ’s Oncology R&D Head On China’s Scientific Promise And True Innovation

UK Major Committed To R&D Presence, Alliances

 
• By Dexter Jie Yan
  
AstraZeneca’s 14 years of deal-making in China could be traced to true innovations. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Deals